Incidence of dizziness and vertigo in Japanese primary care clinic patients with lifestyle-related diseases: an observational study

Figures & data

Table 1 Baseline characteristics of the 393 study participants

Characteristic	Value*
Age (years)	65.5±8.2
Male sex	133 (33.8)
Diabetes mellitus	50 (12.7)
Medications	28 (56)
Hypertension	324 (82.4)
Medications	320 (98.8)
Hyperlipidemia	364 (92.6)
Medications	127 (34.9)
Brinkman Index	226.9±23.3
Smoking status
Never	285 (72.5)
Former	59 (15.0)
Current	49 (12.5)
Ethanol intake (g/day)	8.47±0.95
Drinking status
Never	256 (65.1)
Occasional	41 (10.4)
Current	96 (24.4)
Blood pressure (mmHg)
Systolic	133.0±10.9
Diastolic	77.1±8.5
Triglyceride (mg/dL)	168.5±105.4
Cholesterol (mg/dL)
Total	223.1±40.2
LDL	133.9±33.1
HDL	56.1±14.9
HbA1c (NGSP; %)	5.91±0.59
Cr (mg/dL)	0.69±0.15

Notes:

* Plus-minus values are means ± standard deviation. Numerical values depict the frequency number. Numerical values in parentheses depict the proportion (%).

Abbreviations: LDL, low-density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol; HbA_1c, glycosylated hemoglobin; NGSP, National Glycohemoglobin Standardization Program; Cr, serum creatinine.

Figure 1 Unadjusted cumulative event rates for the endpoints of dizziness and vertigo.

Note: We followed 393 patients and observed 121 new events: dizziness (42) and vertigo (79).

Figure 2 Unadjusted cumulative event rates for the endpoints of APV, BPPV, and MD.

Note: There were 61 cases of APV, 12 of BPPV, and three of MD among the 76 PVD patients.
Abbreviations: PVD, peripheral vestibular disorder; APV, acute peripheral vestibulopathy; BPPV, benign paroxysmal positional vertigo; MD, Meniere’s disease.